CA
SGRY icon

CastleArk Alternatives’s Surgery Partners SGRY Stock Holding History

CastleArk Alternatives’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-167,793
Closed -$7.1M – 240
2021
Q3 		$7.1M Buy
+167,793
New +$8.56M 0.27% 100

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CastleArk Alternatives's SGRY Position: Q4 2021 in Review

CastleArk Alternatives sold out of Surgery Partners (SGRY) in Q4 2021, closing a stake of 167,793 shares — an estimated $7.1M sold.

CastleArk Alternatives first reported a position in SGRY in Q3 2021 and held it in 1 quarter. The position peaked at $7.1M in Q3 2021. 137 funds tracked by Wall St. Rank hold SGRY as of Q4 2021.

  • CastleArk Alternatives reported no remaining Surgery Partners position as of Q4 2021 after selling out during the quarter.
  • CastleArk Alternatives sold 167,793 Surgery Partners shares in Q4 2021, an estimated $7.1M.
  • CastleArk Alternatives first reported a position in Surgery Partners in Q3 2021 and held it in 1 quarter.
  • CastleArk Alternatives's Surgery Partners position peaked at $7.1M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.